| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle.
|
Circ Res
|
2006
|
1.70
|
|
2
|
cAMP-adenosine pathway in the proximal tubule.
|
J Pharmacol Exp Ther
|
2006
|
1.13
|
|
3
|
Extracellular 2,3-cyclic adenosine monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth [corrected].
|
Hypertension
|
2010
|
1.10
|
|
4
|
Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice.
|
J Neurotrauma
|
2010
|
1.04
|
|
5
|
A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells.
|
Hypertension
|
2002
|
0.98
|
|
6
|
Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA.
|
Hypertension
|
2008
|
0.96
|
|
7
|
2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.96
|
|
8
|
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.
|
Hypertension
|
2010
|
0.96
|
|
9
|
Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.
|
J Neurochem
|
2011
|
0.95
|
|
10
|
2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.
|
J Pharmacol Exp Ther
|
2011
|
0.95
|
|
11
|
Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth.
|
J Pharmacol Exp Ther
|
2010
|
0.94
|
|
12
|
CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
|
Hypertension
|
2002
|
0.94
|
|
13
|
Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs.
|
Hypertension
|
2002
|
0.92
|
|
14
|
Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A(2B) receptors.
|
Hypertension
|
2005
|
0.92
|
|
15
|
Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells.
|
Hypertension
|
2002
|
0.92
|
|
16
|
Cytochromes 1A1/1B1- and catechol-O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast.
|
J Clin Endocrinol Metab
|
2004
|
0.91
|
|
17
|
Extracellular guanosine regulates extracellular adenosine levels.
|
Am J Physiol Cell Physiol
|
2012
|
0.89
|
|
18
|
Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.
|
Glia
|
2013
|
0.89
|
|
19
|
Extracellular 2',3'-cAMP and 3',5'-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cells.
|
Am J Physiol Renal Physiol
|
2012
|
0.87
|
|
20
|
Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth.
|
Hypertension
|
2002
|
0.87
|
|
21
|
Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice.
|
Circulation
|
2003
|
0.86
|
|
22
|
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
|
Hypertension
|
2012
|
0.83
|
|
23
|
Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
|
J Pharmacol Exp Ther
|
2013
|
0.82
|
|
24
|
Catecholamines block the antimitogenic effect of estradiol on human coronary artery smooth muscle cells.
|
J Clin Endocrinol Metab
|
2004
|
0.82
|
|
25
|
Phospholipase C and Src modulate angiotensin II-induced cyclic AMP production in preglomerular microvascular smooth-muscle cells from spontaneously hypertensive rats.
|
J Cardiovasc Pharmacol
|
2007
|
0.82
|
|
26
|
Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans.
|
J Cereb Blood Flow Metab
|
2007
|
0.81
|
|
27
|
Role of RACK1 in the differential proliferative effects of neuropeptide Y(1-36) and peptide YY(1-36) in SHR vs. WKY preglomerular vascular smooth muscle cells.
|
Am J Physiol Renal Physiol
|
2013
|
0.80
|
|
28
|
Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
|
Am J Physiol Renal Physiol
|
2012
|
0.80
|
|
29
|
Catecholamines block 2-hydroxyestradiol-induced antimitogenesis in mesangial cells.
|
Hypertension
|
2002
|
0.80
|
|
30
|
Regulation of Cell Proliferation by the Guanosine-Adenosine Mechanism: Role of Adenosine Receptors.
|
Physiol Rep
|
2013
|
0.80
|
|
31
|
Receptor for activated protein kinase C1 regulates cell proliferation by modulating calcium signaling.
|
Hypertension
|
2011
|
0.79
|
|
32
|
Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol.
|
J Clin Endocrinol Metab
|
2004
|
0.79
|
|
33
|
Catecholamines block the antimitogenic effect of estradiol on human glomerular mesangial cells.
|
Hypertension
|
2003
|
0.77
|
|
34
|
Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism.
|
Hypertension
|
2008
|
0.77
|
|
35
|
Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells.
|
J Clin Endocrinol Metab
|
2010
|
0.77
|
|
36
|
Tibolone and its metabolites induce antimitogenesis in human coronary artery smooth muscle cells: role of estrogen, progesterone, and androgen receptors.
|
J Clin Endocrinol Metab
|
2004
|
0.77
|
|
37
|
A novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesions.
|
Dig Dis Sci
|
2014
|
0.76
|
|
38
|
Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats.
|
Hypertension
|
2010
|
0.75
|